Stockscreener 앱 받기
41.72
0.22%
0.09
시장 영업 전:
41.99
0.27
+0.65%
전일 마감가:
$41.63
열려 있는:
$42.23
하루 거래량:
567.99K
Relative Volume:
1.08
시가총액:
$2.27B
수익:
$1.24B
순이익/손실:
$23.68M
주가수익비율:
99.33
EPS:
0.42
순현금흐름:
$108.67M
1주 성능:
-15.72%
1개월 성능:
-13.19%
6개월 성능:
-15.85%
1년 성능:
-24.48%
1일 변동 폭
$41.06
$42.32
1주일 범위
$40.37
$47.48
52주 변동 폭
$40.37
$64.47
Livanova Plc Stock (LIVN) Company Profile
명칭
Livanova Plc
전화
4402033250662
주소
20 EASTBOURNE TERRACE, LONDON
LIVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
41.72 | 2.27B | 1.24B | 23.68M | 108.67M | 0.42 |
|
ABT
Abbott Laboratories
|
140.22 | 243.19B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.87 | 154.76B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
394.88 | 150.68B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
94.30 | 120.92B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.39 | 42.11B | 5.72B | 4.17B | 490.10M | 6.97 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 개시 | Goldman | Buy |
| 2024-09-17 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 재확인 | Needham | Buy |
| 2024-02-20 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-04-14 | 개시 | Mizuho | Neutral |
| 2022-12-21 | 개시 | Barclays | Equal Weight |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-02-24 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-03 | 개시 | Goldman | Buy |
| 2021-08-20 | 재확인 | Needham | Buy |
| 2021-07-20 | 업그레이드 | Needham | Hold → Buy |
| 2021-03-03 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-01-05 | 다운그레이드 | Needham | Buy → Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-06-26 | 재확인 | Needham | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-02-28 | 재확인 | Needham | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-08 | 개시 | Stifel | Buy |
| 2018-05-31 | 재확인 | Needham | Buy |
| 2018-02-28 | 재확인 | Needham | Buy |
모두보기
Livanova Plc 주식(LIVN)의 최신 뉴스
Cardiac Surgery Devices Market Size, Share, Industry Trends, - openPR
LivaNova (NASDAQ:LIVN) Given New $60.00 Price Target at Mizuho - MarketBeat
Needham & Company LLC Has Lowered Expectations for LivaNova (NASDAQ:LIVN) Stock Price - MarketBeat
LivaNova (NASDAQ:LIVN) Issues FY 2025 Earnings Guidance - MarketBeat
LivaNova (NASDAQ:LIVN) Hits New 12-Month LowTime to Sell? - MarketBeat
7 Best Medical Technology Stocks To Buy According To Analysts - Insider Monkey
Stifel Nicolaus Lowers LivaNova (NASDAQ:LIVN) Price Target to $60.00 - MarketBeat
LivaNova (NASDAQ:LIVN) Issues FY25 Earnings Guidance - MarketBeat
LivaNova (NASDAQ:LIVN) Stock Rating Lowered by Wolfe Research - MarketBeat
How To Trade (LIVN) - Stock Traders Daily
Decoding LivaNova PLC (LIVN): A Strategic SWOT Insight - GuruFocus.com
LivaNova’s Roller Coaster Ride: A Glimmer Amidst Investor Skepticism - MotoPaddock
LivaNova PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Simply Wall St
LivaNova PLC Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance
LivaNova (NASDAQ:LIVN) Rating Lowered to "Buy" at StockNews.com - MarketBeat
LivaNova fourth-quarter revenue increases 3.8% to USD 321.8M - Medical Buyer
LivaNova PLC Reports Strong Growth Amid Challenges - TipRanks
LivaNova (NASDAQ:LIVN) Trading Up 4%What's Next? - MarketBeat
Wolfe Research Downgrades LivaNova to Peer Perform From Outperform -February 26, 2025 at 08:20 am EST - Marketscreener.com
LivaNova PLC (NASDAQ:LIVN) Q4 2024 Earnings Call Transcript - Insider Monkey
Mizuho cuts Livanova stock target to $60, maintains Outperform By Investing.com - Investing.com UK
LivaNova Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Livanova (LIVN) PT Lowered to $60 at Mizuho - StreetInsider.com
LivaNova Plc to Host Earnings Call - ACCESS Newswire
LivaNova downgraded to Peer Perform from Outperform at Wolfe Research - TipRanks
Livanova stock rating downgraded at Wolfe Research By Investing.com - Investing.com South Africa
Livanova stock rating downgraded at Wolfe Research - Investing.com
LivaNova PLC (LIVN) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ... - Yahoo Finance
Adult And Pediatric Hemoconcentrators Market Is Booming - openPR
Stifel cuts Livanova stock price target to $60 from $72 - Investing.com India
Stifel cuts Livanova stock price target to $60 from $72 By Investing.com - Investing.com Canada
Livanova Earnings: Anemic Fourth-Quarter Offers Muted End to 2024 - Morningstar
Oversold Conditions For LivaNova (LIVN) - Nasdaq
LivaNova Shares Fall After Q4 Revenue Misses Estimates -February 25, 2025 at 11:35 am EST - Marketscreener.com
LivaNova PLC reports results for the quarter ended December 31Earnings Summary - TradingView
LivaNova stock touches 52-week low at $43.12 amid challenges By Investing.com - Investing.com South Africa
LivaNova PLC earnings beat by $0.01, revenue fell short of estimates - Investing.com South Africa
LivaNova stock touches 52-week low at $43.12 amid challenges - Investing.com
Earnings call transcript: LivaNova Q4 2024 beats EPS forecast, stock dips - Investing.com
LivaNova PLC Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
LivaNova (LIVN) Tops Q4 Earnings Estimates - Yahoo Finance
LivaNova: Q4 Earnings Snapshot - Danbury News Times
Earnings Flash (LIVN) LIVANOVA PLC Posts Q4 Revenue $321.8M, vs. FactSet Est of $324.1M - Marketscreener.com
Earnings Flash (LIVN) LIVANOVA PLC Posts Q4 Adjusted EPS $0.81, vs. FactSet Est of $0.80 - Marketscreener.com
LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance - TradingView
LivaNova plc (LIVN) Tops Q4 EPS by 1c ; Offers Guidance - StreetInsider.com
LivaNova PLC Reports Strong 2024 Financial Performance - TipRanks
Getinge’s surgical perfusion market exit ‘opens door’ for LivaNova - Yahoo Finance
LivaNova To Present At The Barclays Global Healthcare Conference -February 21, 2025 at 09:03 am EST - Marketscreener.com
LivaNova to Present at the Barclays Global Healthcare Conference - Business Wire
Global Magnetic Ablation Catheters Market Poised for Significant Growth, Projected to Reach USD 1,114.4 Million by 2035 Driven by Technological Advancements and Rising Cardiovascular Cases | Future Market Insights, Inc. - GlobeNewswire Inc.
Livanova Plc (LIVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.02%
2.69%
자본화:
|
볼륨(24시간):